$Progenity, Inc.(PROG)$holding for long, finally lose my patient and desperate to sell, as a result no gain, but happy to not lose many penny. Should I do future investment on Progenity. Guys pls advise your opinion. 

$Lucid Group Inc(LCID)$-8.27% down in two night, don't know what actually happen with us stock. Begaining of the year in such condition, don't know what will happen in upcoming days. 

$Lucid Group Inc(LCID)$Lucid going to kill me, whenever I bought this share go down always. When I sold it this share go up. This time I made mistake I used borrow money from tiger trade as a result my money gone due to risk over night value. No I really loose about $500 so far. Don't know how to get back all those money again. I am very much disipointed about this share ups and down. 

$Lucid Group Inc(LCID)$ Why suddenly lucid rocketing, from 8+ to almost $18 dollars and then again go down to $12 and its gradually going down. Whats happening with that, any genius can explain pls. 

$Tesla Motors(TSLA)$Those who bought yesterday good luck to them. Today can sell it and pocket in your profit 

$Tesla Motors(TSLA)$cant believe current Tesla growth. Better don't buy, just wait for final down price. 

BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment. (Reporting by Roxanne Liu and John Horwitz; Editing by William Mallard and Lincoln Feast.)

$Progenity, Inc.(PROG)$Anyone can predict about this company. Future will go up or not. It's seems continuously going down and down. No idea where it will be stop and raise up again. Any prediction will be helpful for me. Please share your thought about this company. 

Anyone can share with me your personal opinion with me. Pfizer Keep going down. - 6.35% already down. Now I m losing my patient. Do you all thing this can go up again. 

$Progenity, Inc.(PROG)$Any hope to go up

$Progenity, Inc.(PROG)$Is there any hope?

$Progenity, Inc.(PROG)$Why progenty keeps going down? Anyone has any info about this 

$Progenity, Inc.(PROG)$Will it go up 

Two tech giants set records on Wall Street this week, but only one is cheering.Amazon’s market capitalization rose $190 billion on Friday, setting a record for the biggest one-day gain for a company on a U.S. exchange, topping Apple’s $179 billion single-day gain last week.The online retail giant’s shares rose 14% a day after it reported fourth quarter earnings that included details about its booming online ad business and a $20 price hike for its popular Prime subscription, which includes free two-day shipping nationwide. Although Amazon’s quarterly guidance missed analysts’ expectations, investors were optimistic about its fast-growing business units like cloud computing.Facebook parent Meta, on the other hand, set a record on Thursday for biggest single-day trading loss on a U.S. exchan

$Pfizer(PFE)$Now giving me pain a lot. Do not know when Pfizer will go up again. It's really redicuolously drop from $61. Now $52.70. Really I am not a good trader. How about you guys. But now is good time to buy Pfizer. 

$Lucid Group Inc(LCID)$51% down, what should I do

$Progenity, Inc.(PROG)$Bit increase from previous position, still far away to go.

$Progenity, Inc.(PROG)$Killing me 

Palantir has only 203 total customers as of Q3 2021, while just 20 of those customers account for 58% of total revenue.Revenue growth in Palantir’s core client cohort slowed to 20% annualized through the first three quarters of 2021 compared to 2020.During 2021, Palantir fundamentally transformed its go-to-market strategy. The company is now using its cash to aggressively invest in other companies (Investees) who agree to purchase Palantir’s software.Management continues to guide for 30% sales growth through mid-decade. However, Palantir’s 3-phase business model hints at sales trending lower excluding its Investee sales.Palantir offers extraordinary long-term growth potential which should place it on the watchlist of all growth investors. The investment case rests on the fulcrum between op